Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.32 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61049 | 0.81 | PTPN7 (0.38) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL8157232 | 0.71 | PTPN7 (0.43) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL6910044 | 0.68 | KDM1A (0.40) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL13973267 | 0.68 | KDM1A (0.47) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL5616843 | 0.66 | KDM1A (0.39) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL5175203 | 0.65 | GPR3 (0.37) | — | |
| SCHEMBL6067197 | 0.63 | — | — | |
| Hydrochloric Acid SCHEMBL7647947 | 0.63 | KDM1A (0.33) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL6303594 | 0.63 | KDM1A (0.36) | HSPA1APTPN7TDP1KDM4EMEN1 | |
| SCHEMBL1452453 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-3902810-B1 | CURABLE COMPOSITIONS COMPRISING TELECHELIC POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3902808-B1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3356374-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-3902807-B1 | ORGANOMETALLIC CHAIN TRANSFER AGENTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-09 | — | — | EP | disclosed |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-12275810-B2 | Telechelic polyolefins and processes for preparing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-12180314-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-31 | — | — | US | disclosed |
| US-12129368-B2 | Curable compositions comprising unsaturated polyolefins | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-10-29 | — | — | US | disclosed |
| EP-4435013-A2 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | Dow Global Technologies LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-1054910-A1 | IMPROVED OLEFIN POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 2000-11-29 | — | — | EP | disclosed |
| EP-1000093-A1 | ZWITTERIONIC CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-1000068-A1 | PERFLUORONAPHTHYL SUBSTITUTED BORON CONTAINING CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-1000069-A1 | CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999048605-A1 | ION EXCHANGED ALUMINIUM-MAGNESIUM OR FLUORINATED MAGNESIUM SILICATE AEROGELS AND CATALYST SUPPORTS THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999041289-A1 | IMPROVED OLEFIN POLYMERIZATION PROCESS | THE DOW CHEMICAL COMPANY (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1999006449-A1 | ZWITTERIONIC CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999006413-A1 | CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1999006412-A1 | PERFLUORONAPHTHYL SUBSTITUTED BORON CONTAINING CATALYST ACTIVATOR | THE DOW CHEMICAL COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129368-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | HSPA1A 3470/4885PTPN7 4526/4885TDP1 1190/4885 |
| US-12590174-B2 | Curable compositions comprising telechelic polyolefins | CCT2, TCP1, ECH1 | HSPA1A 3006/4885PTPN7 3004/4885TDP1 570/4885 |
| US-12351707-B2 | Curable compositions comprising unsaturated polyolefins | ACSL6, ELOVL6, ALOX5 | HSPA1A 3470/4885PTPN7 4526/4885TDP1 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.